Finding myself after treatment
Lillie Killick was 14 years old when diagnosed with leukaemia in 2010. Now 27, she tells us how some of the support she received after treatment helped to inspire her career choices
Lillie Killick was 14 years old when diagnosed with leukaemia in 2010. Now 27, she tells us how some of the support she received after treatment helped to inspire her career choices
Sarah Davis' daughter Emma was diagnosed with acute lymphoblastic leukaemia (ALL) as a 12-year-old. She writes about the support the family received and the progress Emma has made since finishing treatment
Defining the molecular landscape of paediatric and adolescent acute leukaemia in Tanzania
Naomi Shefford-Thomas, CCLG's Health Information Officer, discusses the importance of accessible information, how it works, and the steps CCLG is taking to make its health resources more inclusive and available to everyone.
Nicky Levent’s son, Sam, was diagnosed with retinoblastoma when he was 18 months old. She explains what it means to her family to raise funds for charities and awareness of childhood cancer, and how it’s helped them.
Child Cancer Smart is a public health intervention aiming to empower both the public and healthcare professionals with knowledge about childhood cancer symptoms. Dr Shaarna Shanmugavadivel, CCLG Research Fellow at the University of Nottingham and part of the project team, tells us more.
Lead investigator Susie Aldiss, a research fellow at the University of Surrey, discusses her research, which is funded by a £92,000 award from CCLG.
Sarah Dransfield was diagnosed with bone cancer in March 2012 aged 16. Here, she tells us what helped her during and after treatment and how cancer has changed her outlook on life.
Louise Graham is a clinical specialist paediatric physiotherapist at The Great North Children’s Hospital. She tells us about how she created a physical activity pathway to help children and young people (CYP) with acute lymphoblastic leukaemia (ALL) stay active, and how she hopes to develop this to support all CYP with cancer.